NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
OHSU Knight Cancer Institute
Dana-Farber Cancer Institute
Bristol-Myers Squibb
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center